HRX 2022: GPX Inc: Novel AI Algorithmic Blood Biomarker Monitoring

HRX 22 - GPX Inc. CEO Javier Echenique (GPX Inc., Boston, MA, US) joins us to discuss CardioID - a novel AI Algorithm-based "bloodless blood test" that uses NT-proBNP biomarkers in patient

Metabolites, Free Full-Text

arxiv-sanity

Machine learning predicts the risk of hemorrhagic transformation

Sensors October-1 2020 - Browse Articles

Digital Health

Global patterns of prognostic biomarkers across disease space

Metabolites, Free Full-Text

YMJ :: Yonsei Medical Journal

PDF) Urine 5-Eicosatetraenoic Acids as Diagnostic Markers for Obstructive Sleep Apnea

CardieX Limited

YMJ :: Yonsei Medical Journal

Antioxidants, Free Full-Text